Market Overview

Mölnlycke Health Care Welcomes United States Senator Susan Collins of Maine to the Brunswick, Maine Manufacturing Facility

Share:

Mölnlycke Health Care, a world-leading medical solutions company,
welcomed US Senator Susan Collins (ME) to Mölnlycke's manufacturing
facility in Brunswick. During the visit, Senator Collins had the
opportunity to meet with employees and also spoke with company leaders
about jobs, the economy and healthcare.

Mölnlycke employs approximately 200 people across their Brunswick and
Wiscasset factories. The Brunswick location opened in 2013 and is
located on the former Brunswick Naval Air Station. It's one of the most
highly automated and efficient factories in the world for manufacturing
dressings used in the management of wounds and pressure ulcer
prevention: Mepilex®, Mepilex® Border and Mepilex® Border Flex.

"We are honored to host Senator Collins and her team at our facility and
are proud of the fact that in Maine, we are manufacturing wound care
dressings, backed by clinical evidence, that help to make life better
for millions of people from the hospital to their homes," said Rob
Claypoole, President Mölnlycke US. "Delivering effective medical
solutions that improve outcomes and offer better value is our focus. And
we are grateful that Senator Collins has been an advocate for this with
her efforts in healthcare."

First elected in 1996, Senator Collins has earned a reputation as a
legislator who works across party lines to seek consensus on our
nation's most important issues. She chairs the Senate Select
Committee on Aging
and the Transportation, Housing, and Urban
Development Appropriations Subcommittee
, and also serves on the Intelligence
Committee
as well as the Committee on Health, Education, Labor
and Pensions.
Her work has impacted such areas as homeland security,
national defense, disaster response, education, business development,
healthcare, and issues of particular interest to our nation's seniors.

"Maine is the oldest state in the nation by average age. As the Chairman
of the Senate Aging Committee, I know the importance of Mölnlycke's
advancements in wound care to vulnerable populations recovering from
surgery or injury," said Senator Collins. "Mölnlycke's cutting-edge
Brunswick factory is proof that Maine's manufacturing tradition is
alive, well, and growing. It was a pleasure to visit this facility and
speak with many of the Mainers who work here."

Mark Olmstead, Vice President Government Affairs, Reimbursement and
Health Economics for Mölnlycke, closed the meeting: "We thank Senator
Collins and her staff for visiting with us and recognizing Mölnlycke's
interest to promote treatment and prevention of wounds that lead to
better healthcare outcomes for patients in the US and worldwide."

About Mölnlycke Health Care, U.S., LLC

Mölnlycke is a world-leading medical solutions company. We develop and
bring to market innovative wound care and surgical solutions along the
entire continuum of care – from prevention to post-acute settings. Our
solutions provide value for money, supported by clinical and health
economic evidence. Mölnlycke Health Care is dedicated to reducing
Hospital Acquired Pressure Ulcers (HAPUs). For further information about
Pressure Ulcers, please visit the National
Pressure Ulcer Advisory Panel
website.

Mölnlycke was founded in 1849. Nowadays, our solutions are available in
around 100 countries and we are the number one global provider of
advanced wound care and single-use surgical products. Our corporate
headquarters are in Gothenburg, Sweden and we have about 7,700 employees
around the world. In the US, we operate with about 650 employees with
local headquarters based in Norcross, GA. Our US manufacturing sites are
located in Brunswick and Wiscasset, Maine as well as Indianapolis,
Indiana. Our US distribution centers are located in Anderson, South
Carolina and Sparks, Nevada. Learn more at www.molnlycke.com.

View Comments and Join the Discussion!